Clinical trials: sponsored by Stanford University
Patient Safety, Medical Errors
Specialist Review of Harm Ratings for Clinical Responses Acronym: NOHARM
The purpose of this study is to determine how closely potential-harm ratings assigned using the NOHARM rubric agree with independent ratings from specialty-matched physicians.
- Trial name
- NCT07823062
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Stanford University
Tonsillectomy, Pharyngoplasty
Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management
The goal of this clinical trial is to learn if a non-opioid pain medicine called suzetrigine can lower how much opioid pain medicine adults need after tonsil surgery (tonsillectomy) or a similar throat surgery.
- Conditions
- Tonsillectomy, Pharyngoplasty, Suzetrigine, Opioid
- Trial name
- STOP (NCT07821931)
- Testing
- Suzetrigine, Acetaminophen, oxycodone
- Where
- United States
- Volunteers
- 58 people
- Sponsor
- Stanford University
Chronic Pain, Ketamine
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain.
- Trial name
- ORACLE (NCT07648771)
- Testing
- Ketamine (Ketalar)
- Where
- United States
- Volunteers
- 800 people
- Sponsor
- Stanford University
Brain and Nervous System
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent…
- Trial name
- NCT05474378
- Testing
- B7-H3CART
- Where
- United States
- Volunteers
- 39 people
- Sponsor
- Stanford University
Oropharyngeal Carcinoma, Human Papilloma Virus
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV).
- Trial name
- NCT05880797
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- Stanford University
Cicatrix, Breast Reconstruction
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy.
- Trial name
- NCT05377723
- Testing
- Neodyne Device
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Stanford University
Eating Disorders, Type 1 Diabetes
Eating Disorder Prevention Program for Women With T1D
This study aims to test the effectiveness of an evidence-based eating- disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group.
- Trial name
- NCT05264376
- Testing
- Diabetes Body Project, Educational Control
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- Stanford University
Diabetes, Obesity
Addressing Diabetes by Elevating Access to Nutrition
The goal of ADELANTE is to determine whether a multi-level intervention to improve household food insecurity and glycemic control is effective for Latino patients with diabetes. Specifically, ADELANTE aims to 1.
- Conditions
- Diabetes, Obesity, Lifestyle, Healthy
- Trial name
- ADELANTE (NCT05228860)
- Testing
- Vida Sana (a Group Lifestyle Intervention), Supplemental Healthy Food Deliveries
- Where
- United States
- Volunteers
- 233 people
- Sponsor
- Stanford University
Cancer
Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events
The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies.
- Trial name
- NCT07767448
- Testing
- La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash, La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream, La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+)
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Stanford University
Ovarian Cancer
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
This is a single site, open label, Phase 1 study using a 3 + 3 dose escalation design in two cohorts of adults with recurrent, platinum-resistant ovarian tumors.
- Trial name
- NCT06646627
- Testing
- B7-H3CART
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Stanford University
Plantar Fascitis
Dynamic Versus Static Night Splinting of Plantar Fasciitis
The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.
- Trial name
- NCT05432895
- Testing
- Dynamic splint
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Stanford University
Metastases, Metastatic Cancer
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Unblinded, randomized study of 5-fraction LATTICE radiotherapy (20 Gy with an SIB to 66.7 Gy in 5 fractions) versus moderately dose-escalated palliative radiation (25 Gy in 5 fractions)
- Trial name
- NCT07594431
- Testing
- LATTICE Radiotherapy, Standard radiotherapy
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Stanford University
EGFR, Lung Cancer (NSCLC)
Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC
This study will evaluate the novel, oral EGFR TKI, zipalertinib, in the adjuvant ctDNA-adapted treatment of stage IA2 to IIIC atypical EGFR-mutant NSCLC after completion of definitive therapy with a primary endpoint of molecular…
- Conditions
- EGFR, Lung Cancer (NSCLC), Non Small Cell Lung Cancer
- Trial name
- NCT07802834
- Testing
- Zipalertinib
- Volunteers
- 42 people
- Sponsor
- Stanford University
Leukemia, Acute Lymphoblastic Leukemia
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
The primary purpose of this study is to determine safety, feasibility, and the Maximum Tolerated Dose (MTD)/Recommended Phase 2 Dose (RP2D) of CD22 Chimeric Antigen Receptor T-Cell Therapy (CART) cells when administered 28 to 42…
- Trial name
- NCT06408194
- Testing
- CD22CART infusion, Tisagenlecleucel
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Stanford University
Obesity
Childcare Healthy Beverage Access, Food and Beverage Intake, and Obesity
Interventions that promote water consumption in place of sugar-sweetened beverages have shown promise for preventing childhood obesity in schoolchildren.
- Trial name
- NCT05112185
- Testing
- Healthy Drinks, Healthy Futures
- Where
- United States
- Volunteers
- 1,034 people
- Sponsor
- Stanford University
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.
- Conditions
- BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Blasts More Than 5 Percent of Peripheral Blood White Cells
- Trial name
- NCT03801434
- Testing
- Ruxolitinib
- Where
- 4 sites in United States
- Volunteers
- 8 people
- Sponsor
- Stanford University
Pain Syndrome, Pain Management
Peripheral Neurostimulation for Nerve Block Placement
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management.
- Trial name
- NCT06566664
- Testing
- B Braun HNS 12 nerve stimulator
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Stanford University
Liver Metastases, Tumor
End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.
Patients with liver metastases undergoing planning arteriography for Y-90 administration by interventional radiology will be screened for study enrollment.
- Trial name
- NCT07791446
- Testing
- The TriNav Infusion Systems, Standard End Hole Microcatheter
- Where
- United States
- Volunteers
- 65 people
- Sponsor
- Stanford University
Shared Decision-Making, Quality of Life
Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care
The purpose of the EMBRACE Study is to evaluate whether a facilitated intervention improves shared decision-making (SDM) and patient activation among low-income and minority individuals more than usual care only.
- Conditions
- Shared Decision-Making, Quality of Life, Advanced Illness, Terminal Illness
- Trial name
- EMBRACE (NCT07652359)
- Testing
- Research Assistant Support
- Where
- United States
- Volunteers
- 138 people
- Sponsor
- Stanford University
Anxiety, Parents
Treatment of Parental Anxiety Virtual Reality (VR)
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and…
- Conditions
- Anxiety, Parents, Virtual Reality, State Anxiety
- Trial name
- NCT05729347
- Testing
- Virtual Reality headset with calming scenery
- Where
- United States
- Volunteers
- 485 people, healthy volunteers welcome
- Sponsor
- Stanford University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.